Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Public health

Government-backed national academy to promote social prescribing

An independent national academy will support healthcare professionals in prescribing arts, sport and leisure activities to more patients, the health secretary Matt Hancock has announced.

The academy, which was developed in partnership with Sport England, Arts Council England and other voluntary sector organisations, will be given £5m of government funding and headed up by Helen Stokes-Lampard, the outgoing chair of the Royal College of General Practitioners.

The government said it will work to standardise the quality and range of social prescribing available across the country; champion the benefits of social prescribing; build the evidence base behind it; and share and develop best practice in this area.

The scheme builds on commitments laid out in the ‘NHS long-term plan’ to refer at least 900,000 people to social prescribing within five years, with the help of 1,000 social prescribing link workers, starting in 2020/2021.

“Social prescribing has always been so close to my heart as a practising GP,” said Stokes-Lampard.

“I’m looking forward to starting work with colleagues from so many sectors to bring social prescribing into the mainstream, to train and educate social prescribers of the future and to establish a great evidence base and raise the profile of this fantastic initiative.”

Jo Churchill, minister for primary care, public health and prevention, said the role of social prescribing in keeping people healthy “should not be underestimated”.

“It can keep people better engaged in being healthier, happier and participating more in their communities, while potentially reducing the need to see a GP,” she said.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207232

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.